Gilead Sciences Inc:Gilead Sciences Inc - New Phase 3 Data Support Sustained, Long-Acting Efficacy Of Lenacapavir, Gilead'S Investigational Hiv-1 Capsid Inhibitor.Gilead Sciences Inc - Lenacapavir Was Generally Well Tolerated, With No Adverse Events.Gilead Sciences Inc - Week 26 Data From Capella Trial Show Lenacapavir Leads To High Rates Of Virologic Suppression.
- 170
- 25
- Favorite
Gilead Says Phase 3 Data Support Sustained, Long-Acting Efficacy Of Lenacapavir
T-Reuters2021-07-17
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
170
Report
Login to post
- EHG·2021-07-19LikeLikeReport
- Investor_RG·2021-07-18Hello2Report
- CPKoh·2021-07-18Great2Report
- Kukudosmin·2021-07-18Ok1Report
- Ei_888·2021-07-18Ok1Report
- Tomcatanty·2021-07-18Wow4Report
- Summerlim·2021-07-18Good3Report
- Jfm9513·2021-07-18good4Report
- QuantumQuil·2021-07-18Boom5Report
- KFChen·2021-07-18Wow3Report
- WarisHeng·2021-07-18Good3Report
- Jackytan·2021-07-18Nice1Report
- SeanSak·2021-07-18Like n comment3Report
- sfleong1·2021-07-18Like n comment3Report
- Jazling·2021-07-18Wow3Report
- SPOT_ON·2021-07-18Like n follow3Report
- Ming83·2021-07-18Hi3Report
- james_l·2021-07-18Nice4Report
- AccX·2021-07-18Great4Report
- LaughingGold·2021-07-18Time to moon4Report
Most Discussed
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email：uservice@ttm.financial